Central Nervous System

Delivering global market research insights in the central nervous system therapy area

An ageing population, increased life expectancy and the launch of new products are all driving future growth of the CNS market.

Covering a wide range of conditions affecting the nervous system, major diseases include Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, diabetic neuropathy, major depressive disorder (MDD), bipolar disorder, schizophrenia, insomnia, epilepsy, attention deficit hyperactivity disorder (ADHD) and migraine.

The markets for Alzheimer’s disease and multiple sclerosis are expected to witness particular growth due to expected launch of promising molecules with disease- modifying characteristics and novel mechanisms of action.

We can help you with:

  • Opportunity and demand assessment

  • Understanding the global and local market opportunity

  • The patient journey and unmet needs

  • Segmenting the market

  • Product and portfolio development

  • Brand positioning, launch and beyond

Central Nervous System resources:

Mental health in the Asia Pacific region- small resource image

Article

Out of the shadows: Mental health in the Asia Pacific region.





Find out more

Reforming mental healthcare in Latin America and the Caribbean- small resource image

Article

Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean.


Find out more

How mobile diaries were used to capture patient-generated insights in COPD

Case study

How in-depth insights were used to develop an effective product development strategy in MS.


Learn more